Entecavir HPLC-MS/MS quantitation and optimized sample preparation using human plasma: Validation in a pharmacokinetic study
Int. Journal of Clinical Pharmacology and Therapeutics · 01.02.2026 · 64 (02) · 47-56
DOI: 10.5414/cp204582 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 01.02.2026. Verfasst von Rui Zhao und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Guanine, Antiviral Agents.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Zhao, R., Li, P., Liu, H., Du, P., & Liu, L. (2026). Entecavir HPLC-MS/MS quantitation and optimized sample preparation using human plasma: Validation in a pharmacokinetic study. Int. Journal of Clinical Pharmacology and Therapeutics, 64(02), 47-56. https://doi.org/10.5414/cp204582
Vancouver
Zhao R, Li P, Liu H, Du P, Liu L. Entecavir HPLC-MS/MS quantitation and optimized sample preparation using human plasma: Validation in a pharmacokinetic study. Int. Journal of Clinical Pharmacology and Therapeutics. 2026;64(02):47-56. doi:10.5414/cp204582
BibTeX
@article{Zhao2026,
author = {Zhao, Rui and Li, Pengfei and Liu, Hongchuan and Du, Ping and Liu, Lihong},
title = {Entecavir HPLC-MS/MS quantitation and optimized sample preparation using human plasma: Validation in a pharmacokinetic study},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
volume = {64},
number = {02},
pages = {47--56},
doi = {10.5414/cp204582}
}
EUVIMED